You cannot argue with OTC pink current reporting. It was long overdue but McHenry did finally file the quarterly. It would be beneficial if McHenry would just explain the net loss with the revenues. Also what is the hold up on realizing revenues. What is the CEO's plan to pay those outstanding payables? The revenue to be collected will not cover all the expenses. A little information from the CEO in an OTC news would suffice. Maybe we get it maybe we don't.